Well done, Jake, thanks for posting. Question: Bes
Post# of 148110
If so - who among them might be the most motivated to want to team up?
With Leronlimab's potential as a platform drug, I'd be surprised if there wasn't a lot of jockeying for position among the BP's while we're so cheap.